Elliott Levy joins Amgen from BMS

Dr Elliott Levy has left his role at Bristol-Myers Squibb to join Amgen as senior VO, global development.

Levy was most recently senior VP and head of specialty development at BMS, where he spent 17 years.

During this time he served in a number of senior roles including head of global pharmacovigilance and epidemiology.

“Elliott brings a wealth of development and leadership experience to his new role at Amgen,” said Dr Sean Harper, executive VP of R&D at Amgen.

“His track record shows his success in leading major clinical development programmes, and we're confident that he will help Amgen to serve patients by advancing the large number of potential new medicines in our late-stage pipeline.”